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ABSTRACT
Objectives: While multiple studies have demonstrated
variations in the quality of cancer care in the USA,
payers are increasingly assessing structure-level and
process-level measures to promote quality
improvement. Hospital-acquired adverse events are one
such measure and we examine their national trends
after major cancer surgery.
Design: Retrospective, cross-sectional analysis of a
weighted-national estimate from the Nationwide
Inpatient Sample (NIS) undergoing major oncological
procedures (colectomy, cystectomy, oesophagectomy,
gastrectomy, hysterectomy, lung resection,
pancreatectomy and prostatectomy). The Agency for
Healthcare Research and Quality Patient Safety
Indicators (PSIs) were utilised to identify trends in
hospital-acquired adverse events.
Setting: Secondary and tertiary care, US hospitals in NIS
Participants: A weighted-national estimate of 2 508 917
patients (>18 years, 1999–2009) from NIS.
Primary outcome measures: Hospital-acquired
adverse events.
Results: 324 852 patients experienced ≥1-PSI event
(12.9%). Patients with ≥1-PSI experienced higher rates
of in-hospital mortality (OR 19.38, 95% CI 18.44 to
20.37), prolonged length of stay (OR 4.43, 95% CI 4.31
to 4.54) and excessive hospital-charges (OR 5.21, 95%
CI 5.10 to 5.32). Patients treated at lower volume
hospitals experienced both higher PSI events and failure-
to-rescue rates. While a steady increase in the frequency
of PSI events after major cancer surgery has occurred
over the last 10 years (estimated annual % change
(EAPC): 3.5%, p<0.001), a concomitant decrease in
failure-to-rescue rates (EAPC −3.01%) and overall
mortality (EAPC −2.30%) was noted (all p<0.001).
Conclusions: Over the past decade, there has been a
substantial increase in the national frequency of
potentially avoidable adverse events after major cancer
surgery, with a detrimental effect on numerous outcome-
level measures. However, there was a concomitant
reduction in failure-to-rescue rates and overall mortality
rates. Policy changes to improve the increasing burden of
specific adverse events, such as postoperative sepsis,
pressure ulcers and respiratory failure, are required.
ARTICLE SUMMARY
Article focus
▪ Variations in the quality of surgical oncology
care in the USA remain unclear.
▪ Payers are increasingly assessing the structure-
level and process-level measures to promote
quality improvement.
▪ Hospital-acquired adverse events are one such
measure and we examine their national trends
after major cancer surgery.
Key messages
▪ Over the past decade, there has been a substan-
tial increase in the national frequency of poten-
tially avoidable adverse events after major cancer
surgery, but there was also a concomitant reduc-
tion in the failure-to-rescue rates and overall
mortality rates.
▪ Patients treated at lower volume hospitals experi-
enced both a higher frequency of potentially
avoidable adverse events and failure-to-rescue
rates.
▪ Policy changes to improve the increasing burden
of specific adverse events, such as postoperative
sepsis, pressure ulcers and respiratory failure,
are required.
Strengths and limitations of this study
▪ This is the largest study to assess the quality of
oncological surgical care in a nationally repre-
sentative cohort of US patients.
▪ Validated Agency for Healthcare Research and
Quality Patient Safety Indicators (PSIs) were uti-
lised to identify trends in hospital-acquired
adverse events.
▪ Inherent to the retrospective analyses of large
administrative datasets, this study is limited by
potential biases due to the case-mix and
miscoding.
▪ While PSIs have been shown to perform well as
screening tools from an epidemiological per-
spective (overidentification and few false-
negatives), concerns related to high false-
positive rates exist.
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INTRODUCTION
There has been much interest in assessing the down-
stream effects and complexities of the contemporary
delivery of healthcare. However, observational studies
examining preventable adverse events are confounded
by the loss of information when administrative data are
abstracted from patient records. Recently, several initia-
tives have been directed to improve consistency, rele-
vance and ﬁdelity in the process of transforming clinical
data into administrative datasets and subsequent
practice-changing results. Following a landmark study by
Iezzoni et al1 on computerised algorithms to identify
quality-of-care disparities in administrative datasets, the
Agency for Healthcare Research and Quality (AHRQ)
developed a standardised system for accrual and report-
ing of unintended hospital-acquired adverse events,
termed patient safety indicators (PSIs).2 Subsequently,
Zhan and Miller3 examined the relationship between
multiple process-level, setting-level and outcome-level
measures and adverse events identiﬁed using the
AHRQ’s PSI system, and reported substantial but vari-
able effects on the healthcare system.
Nonetheless, there is a paucity of studies evaluating
the burden of preventable adverse events4 and this is
particularly true for major surgical oncology care in the
USA. Multiple studies have demonstrated that signiﬁcant
variation exists in cancer incidence rates5 and in access
to quality cancer care,6 7 but variations in the actual
quality of surgical oncology care remain unclear.
Hence, we undertook a national assessment of the
quality of major surgical oncology care within a standar-
dised framework of preventable adverse events to
examine trends in patient safety within the USA. We also
evaluated the prevailing hypothesis8–10 explaining the
volume–complication–mortality relationship, which states
that higher mortality rates for patients undergoing
surgery at low-volume hospitals are preferentially
explained by higher failure-to-rescue rates (ie, mortality
after a hospital-acquired adverse event), rather than a
higher incidence of such adverse events in the ﬁrst place.
METHODS
Data source
The Nationwide Inpatient Sample (NIS) consists of an
array of longitudinal hospital inpatients datasets as part
of the Healthcare Cost and Utilization Project. It was
established by AHRQ and functions through a
Federal-state afﬁliation. It is the largest publicly access-
ible all-payer inpatient database.11 The database consists
of discharge information from eight million inpatient
visits and patients covered by multiple insurance types
(including Medicare, Medicaid, private insurance and
uninsured patients) are represented.
Study cohort
We relied on hospital discharges for patients undergoing
one of eight major cancer surgeries in the USA between
1999 and 2009. The major oncological surgeries con-
sisted of colectomy, cystectomy, oesophagectomy, gastrec-
tomy, hysterectomy, pneumonectomy/lobectomy,
pancreatectomy and prostatectomy. Oncological indica-
tions were selected based on International Classiﬁcation
of Diseases-9 (ICD-9) clinical modiﬁcation diagnostic
codes. These particular procedures were chosen based
on procedure volume and care was taken to include
cancer surgeries involving different organ systems across
a range of surgical specialties.
Patient and hospital information
Patient characteristics evaluated included age at
inpatient hospitalisation, race, gender, insurance charac-
teristics and comorbidities. Regarding race, patients
were classiﬁed as White, Black, Hispanic and Other
(Asian or Paciﬁc Islander, Native American). Regarding
insurance characteristics, patients were categorised
based on the primary payer: Medicare, Medicaid, Private
insurance (Blue Cross, commercial carriers, private
HMO’s and PPO’s) and other insurance types (includ-
ing uninsured patients). Charlson Comorbidity index
(CCI) was derived according to Charlson et al,12 and
adapted according to the previously deﬁned method-
ology of Deyo et al.13 Median household income of the
patient’s ZIP code of residence, as derived from the US
Census, was used to deﬁne socioeconomic status and
patients were divided into quartiles:<$25 000, $25 000–
$34 999, $35 000–$44 999 and ≥$45 000. Hospital infor-
mation examined included hospital location (urban vs
rural) and region (Northeast, Midwest, South and West),
as deﬁned by the USA Census Bureau14 and academic
teaching status as derived from the AHA Annual Survey
of Hospitals. Hospital volume was categorised into
volume quartiles as described previously.15
Primary outcomes
The AHRQ PSIs were used to identify potentially pre-
ventable hospital-acquired adverse events. For the PSI
project, AHRQ commissioned experts from the
Evidence-based Practice Center at the University of
California San Francisco and Stanford University and
from the University of California Davis to evaluate the
existing literature and help develop an evidence-based
approach for improving patient safety.2 The objective of
this project was to facilitate the identiﬁcation, quantiﬁca-
tion and reporting of preventable hospital-acquired
adverse events from routinely collected administrative
information. The process of identiﬁcation of PSI
included initial literature analysis of previously reported
patient safety problems, organised peer review of chosen
PSIs, structured review of ICD-9 codes for each PSI and,
ﬁnally, empirical analysis of each PSI and feedback from
multidisciplinary teams (physicians and specialists,
nurses, pharmacists and coding and experts).2 The com-
plete set of PSIs utilised is displayed in the appendix
and is available on the AHRQ website.16 The list
includes various preventable adverse events that have
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been shown to have reasonable accuracy and validity as
indicators for enhancing quality improvement and
patient safety.
Statistical analysis
Proportions, frequencies, means, medians, SD and IQRs
were obtained for each variable. National trends in the fre-
quency of PSI events, failure to rescue (deﬁned as mortality
after a PSI event), and in-hospital mortality were also ana-
lysed as the estimated annual percentage change (EAPC),
based on the linear regression methodology described by
Anderson et al.17 Logistic regression models were used to
examine predictors of PSI events, and to examine the
effect of PSI events on multiple outcomes-level measures,
including in-hospital mortality, excessive charges (≥75th
centile of inﬂation-adjusted charges for each individual
procedure) and prolonged length of stay (≥75th centile of
each individual procedure). Subsequently, we examined
the volume–complication–mortality relationship in overall
and procedure-speciﬁc analyses to study the relationship
between mortality at low-volume hospitals and
failure-to-rescue rates. Generalised estimating equations
were used in each multivariable analysis to adjust for clus-
tering among hospitals.18 All analyses were two-sided, and
signiﬁcance was deﬁned as p<0.05 and performed using
the R statistical package (R foundation for Statistical
Computing, V.2.15.1).
RESULTS
The baseline demographic characteristics of our cohort
of patients >18 years old undergoing one of eight major
cancer procedures in the USA between 1999 and 2009
(n=2 508 917) are shown in table 1. A weighted estimate
of 324 852 patients experienced ≥1-PSI event (12.9%).
Patients with ≥1-PSI event were more likely to be older,
be women, have higher CCI, participate in Medicare,
have lower socioeconomic status, and be treated at lower
volume non-academic hospitals when compared with
patients who did not experience any hospital-acquired
preventable adverse events.
The national trends in PSI rates, overall mortality rates
and failure-to-rescue rates in patients undergoing major
cancer surgery in the USA are depicted in ﬁgure 1.
While a steady increase in the frequency of PSI-events
after major cancer surgery has occurred over the last
10 years (EAPC 3.5%; 95% CI 2.8% to 4.1%; p<0.001), a
concomitant decrease in failure-to-rescue rates (EAPC
−3%; 95% CI −3.4% to −2.6%; p<0.001) and overall
mortality (EAPC −2.3%; 95% CI −2.7% to −1.9%;
p<0.001) was noted.
While there was a signiﬁcant increase in overall PSI event
rates over the course of the study, substantial heterogeneity
was noted in terms of individual PSIs (ﬁgure 2A–C).
Substantial increases were noted in the annual incidence
of postoperative sepsis (EAPC 14.1%, 95% CI 12.0% to
16.2%; p<0.001), pressure ulcer (EAPC 13.4%, 95% CI
10.2% to 16.6%; p<0.001) and respiratory failure (EAPC
5.6%, 95% CI 4.8% to 6.4%; p<0.001), while signiﬁcant
advances were made in the prevention of anaesthetic com-
plications (EAPC −17.5%, 95% CI −27.6% to −7.5%;
p=0.008), hip fractures (EAPC −8.9%, 95% CI −13.6% to
−4.3%; p=0.005) and transfusion reactions (EAPC −7.9%,
95% CI −13.1% to −2.8%; p=0.001) in the perioperative
period.
Results of a multivariable logistic regression model
predicting the odds of ≥1-PSI event after major cancer
surgery are shown in table 2. These factors included:
female gender (vs male, OR 0.88, 95% CI 0.86 to 0.90;
p<0.001), Black race (vs Caucasians OR 1.17, 95% CI
1.13 to 1.21; p<0.001), higher CCI (≥3 vs 0, OR 1.38,
95% CI 1.34 to 1.42; p<0.001), Medicaid (OR 1.45, 95%
CI 1.39 to 1.52) and Medicare insurance (OR 1.16, 95%
CI 1.13 to 1.19; p<0.001), lower median household
income (4th quartile vs 1st quartile, OR 0.92, 95% CI
0.89 to 0.95; p<0.001) and surgeries at lower volume hos-
pitals (4th quartile vs 1st quartile, OR 0.76, 95% CI 0.74
to 0.78; p<0.001).
The occurrence of ≥1-PSI event had signiﬁcant multi-
variable effects on speciﬁc outcome-level measures after
major cancer surgery (table 3). Patients who suffered
from ≥1-PSI event experienced higher rates of
in-hospital mortality (OR 19.38, 95% CI 18.44 to 20.37),
prolonged length of stay (OR 4.43, 95% CI 4.31 to 4.54)
and excessive hospital charges (OR 5.21, 95% CI 5.10 to
5.32).
We also assessed the effect of hospital volume on the
incidence of PSIs and failure to rescue (table 4). In the
overall analysis of patients undergoing any of the eight
procedures, very high-volume hospitals (4th quartile)
had both a lower PSI event rate and lower
failure-to-rescue rates. However, this relationship was
procedure-speciﬁc: for colectomy, oesophagectomy, lung
resection, pancreatectomy and prostatectomy, very high-
volume hospitals had both lower PSI event rates and
lower failure-to-rescue rates. For gastrectomy, very high-
volume hospitals did not have lower PSI event rates but
they did have lower failure-to-rescue rates; for hysterec-
tomy, very high-volume hospitals had higher PSI event
rates, but had lower failure-to-rescue rates; for cystec-
tomy, very high volume-hospitals had lower PSI event
rates and a trend towards lower failure-to-rescue rates.
DISCUSSION
Recently, it has been estimated that the annual cost of
medical errors is over 17 billion dollars19 and there have
been a slew of newer initiatives over the last decade to
incentivise better quality care. In 2008, Medicare
announced that it would restrain the ability of hospitals
to get reimbursed for ‘reasonably preventable events’:
avoidable medical errors ranging from pressure ulcers,
falls and transfusion of incompatible blood to anaes-
thetic complications, deep vein thrombosis and foreign
bodies left in the body of patients during surgery. These
and other initiatives are designed to place the burden of
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responsibility for such hospital-acquired adverse events
squarely on hospitals and physicians.20 While these
initiatives have been met with stiff objection from hos-
pital administrations, the Centers for Medicaid and
Medicare Services (CMS) has been consistent in its pos-
ition that accountability for such events should rest with
hospitals and not with the taxpayer.20 The Affordable
Care Act of 2010 has added newer dimensions to these
quality-improvement initiatives, with reimbursement
likely to be dependent on both adherence to standards
of care and the perceptions of patients with regard to
hospital performance as measured by surveys.21
Table 1 Baseline characteristics of patients >18 years undergoing major cancer surgery, Nationwide Inpatient Sample,
1999–2009
Variables Baseline characteristics
Overall (%) Without PSI event (%) With PSI event (%) p Value
Weighted number of patients 2 508 917 2 184 065 (87.1) 324 852 (12.9) –
Age (years)
Mean (SD) 65.9 (11.7) 65.4 (11.6) 69.5 (11.7) <0.001†
Median (IQR) 66 (5874) 65 (5773) 71 (6278)
Gender
Male 1 511 361 (60.3) 1 331 716 (61.1) 179 645 (55.3) <0.001*
Female 993 704 (39.7) 848 527 (38.9) 145 177 (44.7)
Race
Caucasian 1 525 021 (60.8) 1 324 373 (60.6) 200 648 (61.8) <0.001*
Black 177 986 (7.1) 154 028 (7.1) 23 958 (7.4)
Hispanic 98 532 (3.9) 86 128 (3.9) 12 404 (3.8)
Other 93 041 (3.7) 81 492 (3.6) 11 549 (3.6)
Unknown 614 337 (24.5) 76 293 (23.5) 76 293 (23.5)
CCI
0 1 566 723 (62.4) 1 412 545 (64.7) 154 178 (47.5) <0.001*
1 623 985 (24.9) 516 640 (23.7) 107 345 (33.0)
2 127 538 (5.1) 102 276 (4.7) 25 262 (7.8)
≥3 190 670 (7.6) 152 603 (7.0) 38 067 (11.7)
Insurance status
Private 1 057 919 (42.2) 968 015 (44.3) 89 904 (27.7) <0.001*
Medicaid 80 666 (3.2) 66 947 (3.1) 13 719 (4.2)
Medicare 1 265 920 (50.5) 1 056 618 (48.4) 209 302 (64.4)
Other 104 412 (4.2) 92 485 (4.2) 11 927 (3.7)
Median household income by ZIP code
1–24 999 369 796 (14.7) 313 652 (14.4) 56 144 (17.3) <0.001*
25 000–34 999 596 202 (23.8) 513 758 (23.5) 82 444 (25.4)
35 000–44 999 646 869 (25.8) 563 398 (25.8) 83 471 (25.7)
45 000+ 842 375 (33.6) 746 499 (34.2) 95 876 (29.5)
Unknown 53 672 (2.1) 46 757 (2.1) 6915 (2.1)
Annual hospital volume
1st quartile 591 675 (23.6) 510 024 (23.4) 81 651 (25.1) <0.001*
2nd quartile 640 229 (25.5) 551 980 (25.3) 88 249 (27.2)
3rd quartile 636 482 (25.4) 554 325 (25.4) 82 157 (25.3)
4th quartile 640 531 (25.5) 567 737 (26.0) 72 794 (22.4)
Hospital location
Rural 268 349 (10.7) 235 606 (10.8) 32 743 (10.1) <0.001*
Urban 2 239 651 (89.3) 1 947 705 (89.2) 291 946 (89.9)
Hospital region
Northeast 526 593 (21.) 458 684 (21.0) 67 909 (20.9) <0.001*
Midwest 608 988 (24.3) 532 951 (24.4) 76 037 (23.4)
South 8 822 566 (35.2) 762 212 (34.9) 120 354 (37.0)
West 490 770 (19.6) 430 218 (19.7) 60 552 (18.6)
Hospital teaching status
Non-teaching 1 135 065 (45.3) 979 636 (44.9) 155 429 (47.9) <0.001*
Teaching 1 372 935 (54.7) 1 203 675 (55.1) 169 260 (52.1)
*A chi-square test was performed.
†A Mann-Whitney test was performed.
CCI, Charlson Comorbidity index; PSI, Patient Safety Indicator.
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A rational approach to improving accountability for
substandard care should begin with identifying the true
burden of hospital-acquired adverse events. This would
be particularly useful in identifying speciﬁc adverse
events that warrant special attention by payers like CMS
and in preferential allocation of resources by hospitals
due to the growing temporal burden of such events.
In the current study, we report contemporary trends
in the frequency of hospital-acquired adverse events
after major surgical oncology care in the USA. Our
study has a number of novel ﬁndings. First, we report a
gradual increase in the national frequency of
hospital-acquired adverse events after major cancer
surgery over the last decade. This is important as it
represents a decline, albeit small and gradual, in the
quality of surgical oncology care at the national level, as
measured by the primary prevention of PSI events. The
increase may be attributed to changes in case-mix,
including an ageing population. Conversely, the emer-
gence of multiresistant bacteria may contribute to the
recorded trends.22 23 Second, a simultaneous decrease
in failure-to-rescue rates was observed, which may indi-
cate that while primary prevention of hospital-acquired
adverse events has deteriorated, the early recognition
and timely management of these complications may
have improved in the last decade. These ﬁndings may
explain the signiﬁcant annual reduction in mortality for
patients undergoing major cancer surgery. Nonetheless,
alternate explanations include reﬁnements in coding
practices, which may have led to better recognition and
recording of non-lethal adverse events, thereby resulting
in an apparent decrease in mortality rates. Third,
Figure 2 (A–C) National trends in individual Patient Safety Indicators over the study period (1999–2009) in patients undergoing
major cancer surgery (MCS) in the USA.
Figure 1 National trends in Patient Safety Indicator (PSI)
rates, overall mortality rates and failure-to-rescue rates in
patients undergoing major cancer surgery (MCS) in the USA
(1999–2009); EAPC-estimated annual percentage change.
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signiﬁcant heterogeneity in the temporal dynamics of
speciﬁc hospital-acquired adverse events was noted.
While marked and worrisome increases were recorded
in the frequency of postoperative sepsis, pressure ulcers
and respiratory failure, advances were made in the pre-
vention of anaesthetic complications, transfusion-related
complications and hip fractures. Thus, we identify
numerous setting-level and process-level measures where
resources need to be refocused for further improvement
in the quality of surgical oncology care.
We also examined the volume-complication-mortality
dynamic in patients undergoing major cancer surgery, as
it applies to potentially preventable hospital-acquired
adverse events (PSI). There is a well-established body of
evidence describing the volume-mortality relationship in
patients undergoing major cancer procedures and other
Table 2 Multivariable logistic regression predicting occurrence of at least one patient safety indicator event
Multivariable predictors of ≥1 PSI event*
Variables OR (95% CI) p Value
Weighted number of patients
Age (years) 1.018 (1.017 to 1.019) <0.001
Gender
Male 1.0 (ref.) –
Female 0.878 (0.862 to 0.895) <0.001
Race
Caucasian 1.0 (ref.) –
Black 1.172 (1.132 to 1.213) <0.001
Hispanic 0.973 (0.930 to 1.019) 0.245
Other 0.938 (0.895 to 0.983) 0.008
Unknown 1.010 (0.988 to 1.033) 0.366
CCI
0 1.0 (ref.) –
1 1.227 (1.203 to 1.252) <0.001
2 1.188 (1.147 to 1.230) <0.001
≥3 1.377 (1.336 to 1.419) <0.001
Insurance status
Private 1.0 (ref.) –
Medicaid 1.454 (1.388 to 1.523) <0.001
Medicare 1.155 (1.127 to 1.185) <0.001
Other 1.127 (1.075 to 1.181) <0.001
Median household income by ZIP code
1–24 999 1.0 (ref.) –
25 000–34 999 0.986 (0.959 to 1.013) 0.305
35 000–44 999 0.960 (0.934 to 0.987) 0.004
45 000+ 0.920 (0.894 to 0.946) <0.001
Unknown 1.003 (0.943 to 1.067) 0.929
Annual hospital volume
1st quartile 1.0 (ref.) –
2nd quartile 0.945 (0.922 to 0.969) <0.001
3rd quartile 0.883 (0.860 to 0.907) <0.001
4th quartile 0.761 (0.739 to 0.783) <0.001
Hospital location
Rural 1.0 (ref.) –
Urban 1.236 (1.198 to 1.275) <0.001
Hospital region
Northeast 1.0 (ref.) –
Midwest 0.991 (0.964 to 1.019) 0.541
South 1.049 (1.024 to 1.075) <0.001
West 1.018 (0.989 to 1.047) 0.229
Hospital teaching status
Non-teaching 1.0 (ref.) –
Teaching 0.972 (0.952 to 0.992) 0.007
*Other predictors included procedure type (colectomy-ref; cystectomy (OR 1.51, 95% CI 1.45 to 1.57), oesophagectomy (OR 5.16, 95% CI
4.81 to 5.54), gastrectomy (OR 2.01, 95% CI 1.93 to 2.09), hysterectomy (OR 0.56, 95% CI 0.54 to 0.58), lung resection (OR 2.44, 95% CI
2.39 to 2.50), pancreatectomy (OR 1.79, 95% CI 1.71 to 1.88), prostatectomy (OR 0.26, 95% CI 0.25 to 0.27)) and year of surgery (OR
1.037, 95% CI 1.034 to 1.040). All p<0.001.
CCI, Charlson Comorbidity index; PSI, Patient Safety Indicator.
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surgeries. Dudley et al24 examined patients undergoing 1
of 11 diverse procedures (ranging from coronary angio-
plasty to oesophageal cancer surgery) in California and
concluded that 602 deaths could have been prevented
annually by transferring patients from low-volume to
high-volume hospitals. Birkmeyer et al25 reported that
Medicare patients treated at very high-volume hospitals
experienced up to a 12% difference in absolute mortal-
ity for certain procedures relative to patients treated at
very low-volume hospitals. However, the underlying
mechanisms explaining the volume-mortality relation-
ship have not been elucidated clearly. Silber et al26 ﬁrst
introduced the concept of ‘failure-to-rescue’ in a seminal
report that evaluated patients undergoing cholecystectomy
or transurethral prostatectomy. They concluded that
overall mortality was related to both hospital-level and
patient-level factors, while adverse events were related to
patient-level factors at admission (severity of illness).
However, failure-to-rescue was preferentially associated
with hospital-level factors, and thus the underlying dynam-
ics for failure-to-rescue were different than that for overall
mortality and adverse events. The current hypothesis8
regarding the volume-complication-mortality relationship
is that lower volume hospitals experience higher mortality
rates not because of higher complication rates, but due to
lower failure-to-rescue rates. Ghaferi et al10 demonstrated
that high-volume and low-volume hospitals enrolled in the
National Surgical Quality Improvement Program had
similar complication rates but different failure-to-rescue
rates for multiple procedures. In a subsequent analysis9 of
patients undergoing gastrectomy, pancreatectomy or oeso-
phagectomy, similar results were demonstrated. However,
in the current study, very high-volume hospitals (4th quar-
tile vs 1st quartile) had both lower PSI event rates
and lower failure-to-rescue rates. Importantly, the
volume-complication-mortality relationship, as it applies to
PSI events, appears to be procedure-speciﬁc and heteroge-
neous, with the current hypothesis not accounting for
multiple individual major cancer surgeries, namely colec-
tomy, oesophagectomy, lung resection, pancreatectomy
and prostatectomy. This is an important point: CMS cur-
rently focuses its quality-improvement initiatives on com-
plication rates, and explicit demonstration that lower
failure-to-rescue rates and not higher complication rates
underlying the substandard care at low-volume hospitals
may require a reconsideration of these initiatives. Our
ﬁndings indicate that the prevailing hypothesis may need
to be re-evaluated, at least for patients undergoing major
cancer surgery. In fact, for patients undergoing hysterec-
tomy, this relationship is reversed, with patients at very
high-volume hospitals experiencing higher PSI event rates
and lower failure-to-rescue rates. The underlying reason
for this ﬁnding is not clear. Previous studies27 have ques-
tioned the impact of hospital volume on hysterectomy out-
comes and reported that surgeon volume trumps hospital
volume as the predominant factor underlying the volume–
outcomes relationship for hysterectomy. While the inclu-
sion of surgeon volume may alter these ﬁndings, the
higher rates of adverse events in patients undergoing hys-
terectomy at very high-volume hospitals may need to be
re-examined in future reports.
Our study is not without limitations. The drawbacks of
using administrative data are well known,28 including
limitations regarding risk-adjustment and miscoding.
While PSIs have been shown to perform well as screen-
ing tools from an epidemiological perspective (overiden-
tiﬁcation and few false-negatives), problems related to
high false-positive rates exist, with most validation studies
reporting positive predictive values of between 43% and
>90%.29 30 While it is clear that these drawbacks limit
the use of PSIs to make reimbursement decisions or to
compare hospitals, it is unclear how it affects the impli-
cations of our study, where it was used as a screening
tool to identify adverse events.29 30 Second, morbidity
and mortality events in NIS are characterised based on
the index admission, and subsequent readmissions,
while relevant, are not recorded. This may have resulted
in under-recognition of the true burden of adverse
events, mortality and charges after the initial cancer
surgery. Third, while the heterogeneity identiﬁed in the
volume–complication–mortality relationship is a key
ﬁnding in the present report, our study design does not
allow for the identiﬁcation of the underlying mechanisms
explaining these results. It is also important to emphasise
that, in contrast to the previously cited studies where the
overall complication rates were examined, we evaluated
potentially preventable hospital-acquired events only.
Previous investigators have shown that this restricted def-
inition has limitations since not all deaths are accounted
for in a given population sample31; alternatively, these
drawbacks may not apply to studies focusing on patient
safety using PSI as a quality-of-care measure. Hence,
while it may not be illogical to expect lower volume
Table 3 Multivariable effects of ≥1 patient safety
indicator events on in-hospital mortality, prolonged length
of stay and excessive hospital charges in patients
undergoing major cancer surgery in the USA between
1999 and 2009
≥1 Patient safety indicator vs no
PSI
Variables OR (95% CI)* p Value
In-hospital mortality
(n=51 312)†
19.380 (18.439 to 20.368) <0.001
Prolonged length
of stay (n=888 220)
4.426 (4.313 to 4.542) <0.001
Excessive hospital
charges
(n=609 128)
5.207 (5.097 to 5.319) <0.001
*Each of these effects was derived from individual multivariable
logistic regression models adjusted for hospital clustering,
procedure type, age, gender, race, Charlson comorbidity index,
insurance status, socioeconomic status, year of admission,
hospital location, hospital region, hospital volume quartiles and
institutional academic status.
†1457 Patients with missing in-hospital mortality data.
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hospitals to provide substandard care secondary to both
higher rates of preventable adverse events and higher
failure-to-rescue rates, it is certainly possible that a major-
ity of hospital-acquired complications are an inevitable
result of procedure complexity and patient comorbidities
(and not just a failure of setting-level prevention
measures). Consequently, while more rigorous patient
care pathways might explain the lower incidence of pre-
ventable adverse events and subsequent mortality in
higher volume hospitals, for the majority of (non-
preventable) adverse events, the incidence rates would be
the same regardless of hospital volume with lower
Table 4 Impact of hospital volume effect on patient safety indicator event occurrence and on failure to rescue (death after
patient safety indicator event) from individual multivariable logistic regression models adjusted for hospital clustering by
generalised estimating equation in patients undergoing major cancer surgery, Nationwide Inpatient Sample, 1999–2009
Patient safety indicator occurrence* Failure to rescue*
Procedure OR (95% CI) p Value OR (95% CI) p Value
Overall
1st volume quartile 1.0 (ref.) – 1.0 (ref.) –
2nd volume quartile 0.945 (0.922 to 0.969) <0.001 0.920 (0.861 to 0.982) 0.013
3rd volume quartile 0.883 (0.860 to 0.907) <0.001 0.842 (0.784 to 0.904) <0.001
4th volume quartile 0.761 (0.739 to 0.783) <0.001 0.716 (0.661 to 0.775) <0.001
Colectomy
1st volume quartile 1.0 (ref.) – 1.0 (ref.) –
2nd volume quartile 1.007 (0.969 to 1.046) 0.728 1.029 (0.936 to 1.132) 0.553
3rd volume quartile 0.940 (0.902 to 0.980) 0.003 0.978 (0.883 to 1.083) 0.670
4th volume quartile 0.842 (0.805 to 0.881) <0.001 0.831 (0.742 to 0.931) 0.001
Cystectomy
1st volume quartile 1.0 (ref.) – 1.0 (ref.) –
2nd volume quartile 0.816 (0.728 to 0.914) <0.001 0.872 (0.642 to 1.185) 0.382
3rd volume quartile 0.760 (0.672 to 0.860) <0.001 0.691 (0.487 to 0.981) 0.039
4th volume quartile 0.585 (0.509 to 0.671) <0.001 0.706 (0.471 to 1.058) 0.092
Oesophagectomy
1st volume quartile 1.0 (ref.) – 1.0 (ref.) –
2nd volume quartile 0.802 (0.653 to 0.986) 0.037 0.633 (0.432 to 0.928) 0.019
3rd volume quartile 0.687 (0.546 to 0.863) 0.001 0.488 (0.309 to 0.770) 0.002
4th volume quartile 0.479 (0.378 to 0.609) <0.001 0.459 (0.280 to 0.753) 0.002
Gastrectomy
1st volume quartile 1.0 (ref.) – 1.0 (ref.) –
2nd volume quartile 1.043 (0.935 to 1.163) 0.455 1.028 (0.820 to 1.289) 0.812
3rd volume quartile 0.973 (0.866 to 1.093) 0.642 0.847 (0.660 to 1.088) 0.193
4th volume quartile 0.905 (0.795 to 1.030) 0.129 0.709 (0.532 to 0.945) 0.019
Hysterectomy
1st volume quartile 1.0 (ref.) – 1.0 (ref.) –
2nd volume quartile 1.044 (0.930 to 1.172) 0.468 0.955 (0.895 to 1.020 0.168
3rd volume quartile 1.264 (1.118 to 1.428) <0.001 0.874 (0.815 to 0.938) <0.001
4th volume quartile 1.231 (1.083 to 1.399) 0.001 0.758 (0.701 to 0.820) <0.001
Lung
1st volume quartile 1.0 (ref.) – 1.0 (ref.) –
2nd volume quartile 0.954 (0.911 to 1.000) 0.048 0.820 (0.720 to 0.934) 0.003
3rd volume quartile 0.910 (0.866 to 0.956) <0.001 0.755 (0.657 to 0.867) <0.001
4th volume quartile 0.792 (0.750 to 0.836) <0.001 0.643 (0.548 to 0.753) <0.001
Pancreatectomy
1st volume quartile 1.0 (ref.) – 1.0 (ref.) –
2nd volume quartile 0.767 (0.676 to 0.870) <0.001 0.598 (0.460 to 0.775) <0.001
3rd volume quartile 0.539 (0.468 to 0.621) <0.001 0.405 (0.291 to 0.564) <0.001
4th volume quartile 0.416 (0.357 to 0.485) <0.001 0.362 (0.250 to 0.525) <0.001
Prostatectomy
1st volume quartile 1.0 (ref.) – 1.0 (ref.) –
2nd volume quartile 0.772 (0.713 to 0.837) <0.001 1.293 (0.696 to 2.403) 0.415
3rd volume quartile 0.736 (0.673 to 0.805) <0.001 1.335 (0.687 to 2.591) 0.394
4th volume quartile 0.541 (0.488 to 0.600) <0.001 0.293 (0.085 to 1.006) 0.051
*Multivariable models were generated for the overall model and for each procedure individually. Only the OR and 95% CI for hospital volume
are displayed in the table. Other covariates in each model included: age, gender, race, comorbidities, median household income by ZIP
code, hospital location, teaching status, region, year of admission and procedure type (for overall model only).
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failure-to-rescue rates preferentially explaining the low
mortality rates of higher volume hospitals. Further investi-
gation of these ﬁndings is required to test these possibil-
ities and to fully understand the underlying dynamics of
the volume–mortality relationship.
CONCLUSION
Over the past decade, there has been a substantial
increase in the national frequency of potentially avoid-
able hospital-acquired adverse events after major cancer
surgery, with a detrimental effect on numerous
outcome-level measures. However, there was a concomi-
tant reduction in failure-to-rescue rates and, conse-
quently, overall mortality rates. Policy changes and
resource reallocation to improve the increasing burden
of speciﬁc adverse events, such as postoperative sepsis,
pressure ulcer and respiratory failure, are required.
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APPENDIX
Patient safety indicator ICD-9-CM
Anaesthetic complications E8763, E9381, E9382, E9383, E9384, E9385, E9386, E9387,
E9389, 9681, 9682, 9683, 9684, 9687, E8551
Pressure ulcers 7072x, 7070, 70700, 70701, 70702, 70703, 70704, 70705, 70706,
70707,70709
Foreign body 9984, 9987, E871x
Iatrogenic pneumothorax 5121
Central venous catheter-related blood stream infection 99662, 9993, 99931, 99932
Postoperative hip fracture 820xx
Postoperative haemorrhage or haematoma 9981x, 388x, 3941, 3998, 4995, 5793, 6094, 1809, 540, 5412,
6094, 5919, 610, 6998, 7014,7109,7591, 7592, 8604
Postoperative physiological and metabolic derangement
(secondary diabetes or acute kidney failure)
249x, 2501x, 2502x, 2503x, 584x, 586, 9975
Postoperative physiological and metabolic derangement
(dialysis)
3995, 5498
Postoperative respiratory failure 5185X, 51881, 51884, 9672, 9670, 9671, 9604
Postoperative deep vein thrombosis or pulmonary
embolus
4511x, 4512, 45181, 4519, 4534x, 4538, 4539, 4151x
Postoperative sepsis 038x, 038xx, 9980x, 9959x
Postoperative wound dehiscence 5461
Accidental puncture or laceration E870x, 9982
Transfusion reaction 9996x, 9997x, E8760
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